|
H2AFY expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
3.69779995512687E-09 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
8.911600E-01 |
| Stage1-vs-Stage3 |
4.900200E-01 |
| Stage1-vs-Stage4 |
1.211840E-02 |
| Stage2-vs-Stage3 |
5.843600E-01 |
| Stage2-vs-Stage4 |
9.217800E-02 |
| Stage3-vs-Stage4 |
1.648010E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
4.05849998053043E-09 |
| Normal-vs-Asian |
5.55111512312578E-16 |
| Caucasian-vs-AfricanAmerican |
4.277400E-01 |
| Caucasian-vs-Asian |
4.586800E-01 |
| AfricanAmerican-vs-Asian |
2.102200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
7.309700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
4.564700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.450400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.926600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.334780E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.009790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.039970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.349200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.979200E-01 |
| Classical-VS-Follicular |
4.40240000000314E-05 |
| Classical-VS-Other |
7.769600E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
3.903200E-03 |
| Tall-VS-Other |
8.999400E-01 |
| Tall-VS-Normal |
4.19190004929959E-09 |
| Follicular-VS-Other |
1.186620E-01 |
| Follicular-VS-Normal |
1.57369672848517E-11 |
| Other-VS-Normal |
4.437200E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
1.89070981093664E-13 |
| N0-vs-N1 |
6.793800E-01 |
|
|
